Tuberculosis of other female genital organs
ICD-10 A18.18 is a billable code used to indicate a diagnosis of tuberculosis of other female genital organs.
Tuberculosis of the female genital organs is a rare but serious manifestation of extrapulmonary tuberculosis, primarily caused by Mycobacterium tuberculosis. This condition can affect various structures within the female reproductive system, including the ovaries, fallopian tubes, uterus, and vagina. Symptoms may include pelvic pain, abnormal vaginal discharge, and infertility. Diagnosis typically involves a combination of clinical evaluation, imaging studies such as ultrasound or MRI, and microbiological tests, including culture and PCR for Mycobacterium tuberculosis. Treatment usually consists of a multi-drug regimen similar to that used for pulmonary tuberculosis, often requiring a prolonged course of therapy lasting six months or longer. Monitoring for drug resistance is crucial, as some strains may exhibit resistance to first-line anti-tubercular medications. Public health implications are significant, as tuberculosis is a communicable disease, necessitating contact tracing and isolation procedures for active cases to prevent transmission. The rarity of this condition, combined with its complex presentation and treatment requirements, makes accurate coding essential for proper management and reimbursement.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with pelvic pain and a history of tuberculosis exposure.
Awareness of drug resistance patterns and the need for tailored treatment regimens.
Comprehensive gynecological examination findings and imaging results.
Infertility evaluations in patients with a history of tuberculosis.
Coordination with infectious disease specialists for management of tuberculosis.
Used when biopsy of affected genital organs is performed.
Pathology report detailing findings and correlation with tuberculosis.
Infectious disease specialists may need to review pathology results.
Common symptoms include pelvic pain, abnormal vaginal discharge, infertility, and sometimes fever. Symptoms can vary based on the specific organ affected.
Diagnosis typically involves a combination of clinical evaluation, imaging studies, and microbiological tests such as cultures or PCR for Mycobacterium tuberculosis.
Treatment usually involves a multi-drug regimen similar to that for pulmonary tuberculosis, often lasting six months or longer, with close monitoring for drug resistance.
Public health measures include contact tracing, isolation of active cases, and ensuring that patients complete their treatment to prevent transmission.
